Fundraising Fox
🦊/Companies
Sign in

Houdini Bio

5 employees on LinkedIn · 3 known investors

Find your way into Houdini Bio

Houdini Bio develops a DNA design platform using synthetic biology and machine learning to improve genetic medicines. The platform redesigns therapeutic DNA to escape cellular silencing pathways, enabling greater durability, safety, and cost-effectiveness for genetic medicine treatments.

AI & Machine LearningBiotechDeep Tech

Investors · 3

Deep Science VenturesLondon
SCVC LPreported · 2 sourcesLynnwood

Also in the syndicate · 1

Cambridge Enterprise Ventures

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Capital raising in healthtech: GMP Manufacturing, Houdini Bio, Silveray - Healthcare Todayhealthcaretoday.com · Jul 2026Houdini Bio to unlock DNA limits with £1.5m pre-seed roundcambridgeindependent.co.uk · Jul 2026UK BioTech Thalia Therapeutics raises €3.1 million and acquires Sanmirna Therapeutics | EU-Startupseu-startups.com · Jun 2026Houdini Bio raises £1.5M to tackle gene therapy durability challengesenterprise.cam.ac.uk · Jun 2026A Cambridge PhD discovery raised £1.5M led by SCVC to fix gene therapy's costly flaw — TFNtechfundingnews.com · Jun 2026Houdini Bio emerges from stealth with €1.7 million to tackle DNA silencing in gene therapies | EU-Startupseu-startups.com · Jun 2026

Frequently asked questions

What does Houdini Bio do?
Houdini Bio develops a DNA design platform using synthetic biology and machine learning to improve genetic medicines. The platform redesigns therapeutic DNA to escape cellular silencing pathways, enabling greater durability, safety, and cost-effectiveness for genetic medicine treatments.
Who are Houdini Bio's investors?
Houdini Bio's investors include Deep Science Ventures, SCVC LP.